Dr. Christopher T. Lebrun, MD

Dr. Lebrun practices at Advanced Ambulatory Surgical Center - Redlands in Redlands, California.

Dr. Lebrun's NPI, 1710902655, was assigned on July 13, 2006. Dr. Lebrun graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 2001. Dr. Lebrun holds California license C172147.

Dr. Lebrun's primary practice is Advanced Ambulatory Surgical Center - Redlands, at 1901 Lugonia Ave Suite 100, Redlands, CA 92374. The practice phone is (909) 557-1704.

Dr. Lebrun's primary practice is Advanced Ambulatory Surgical Center - Redlands in Redlands, California. Dr. Lebrun is also affiliated with Riverside Community Hospital. The medical group on file is Arrowhead Orthopaedics. Dmand AI also links Dr. Lebrun to 4 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lebrun practices, 3 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Lebrun's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Lebrun is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Lebrun's licenses on file in 9 states: California, Colorado, South Dakota, Florida, Maryland, Pennsylvania, West Virginia, North Dakota and Tennessee.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, broken or dislocated ankle/ or foot, hip replacement, joint pain, leg, ankle or foot fracture, lower back pain and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Lebrun treats.

CMS data shows 372 Medicare services from Dr. Lebrun across 10 procedure codes in 2024, for 195 Medicare patients. Medicare paid $58,327 for them.

CMS counts 195 Medicare patients who saw Dr. Lebrun in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lebrun's median patient age at 60, with 49% women.

In 2024, Dr. Lebrun wrote 90 Medicare Part D claims for 46 patients. 97% of them were for generic drugs. CMS names the drug for 55 of them, across 3 drugs with 11 or more claims each, at $391 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

Dr. Lebrun accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 26 papers to Dr. Lebrun, published from 2012 to 2025. 2018 was the busiest year, with 2. The most frequent topics are Fracture Fixation, Internal, Tibial Fractures and Fracture Fixation, Intramedullary. Dr. Lebrun has published most often in J Orthop Trauma. Dr. Lebrun's most frequent co-authors are Jason Warren Nascone, MD, Marcus Francisco Sciadini, MD and Theodore Thomas Manson, MD.

Dmand AI links Dr. Lebrun to 3 clinical trials. Conditions studied include Fractures, Bone, Pain and Neurologic Manifestations. University of Maryland, Baltimore sponsors the most, 3.

CMS Open Payments shows 82 general payments to Dr. Lebrun from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 23% of the total. Synthes GmbH paid the most, $4,906.

Dr. Lebrun graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 2001.

Dr. Lebrun is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.